These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Ohkawara Y; Lei XF; Stämpfli MR; Marshall JS; Xing Z; Jordana M Am J Respir Cell Mol Biol; 1997 May; 16(5):510-20. PubMed ID: 9160833 [TBL] [Abstract][Full Text] [Related]
68. Regression and prevention of autochthonous tumors induced by 3-methylcholanthrene after injection of a T-cell receptor alpha /beta positive and CD4/CD8 double negative T-cells. Wakasugi H; Miyazaki K; Maruoka H; Kato K; Miyata M; Sugimura T; Terada M Immunol Lett; 1999 Sep; 69(3):329-37. PubMed ID: 10528797 [TBL] [Abstract][Full Text] [Related]
69. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701 [TBL] [Abstract][Full Text] [Related]
70. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors. Nakamoto T; Inagawa H; Takagi K; Soma G Anticancer Res; 2000; 20(6A):4087-96. PubMed ID: 11131677 [TBL] [Abstract][Full Text] [Related]
71. Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 mice. Krawczyk CM; Verstovsek S; Ujházy P; Maccubbin D; Ehrke MJ Cancer Immunol Immunother; 1995 Jun; 40(6):347-57. PubMed ID: 7627991 [TBL] [Abstract][Full Text] [Related]
72. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K; Tanaka T; Takeuchi M Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657 [TBL] [Abstract][Full Text] [Related]
73. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus. Okamoto M; Ohe G; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Ahmed SU; Yoshida H; Moriya Y; Saito M; Sato M Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135 [TBL] [Abstract][Full Text] [Related]
74. Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy. Mulé JJ; Asher A; McIntosh J; Lafreniere R; Shiloni E; Lefor A; Reichert CM; Rosenberg SA Cancer Immunol Immunother; 1988; 26(3):202-8. PubMed ID: 3383204 [TBL] [Abstract][Full Text] [Related]
75. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267 [TBL] [Abstract][Full Text] [Related]
76. T cell involvement in production of tumor necrosis factor: reconstitution experiments with nude mice. Niitsu Y; Watanabe N; Sone H; Neda H; Urushizaki I Jpn J Cancer Res; 1985 May; 76(5):395-9. PubMed ID: 3924713 [TBL] [Abstract][Full Text] [Related]
77. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model. Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515 [TBL] [Abstract][Full Text] [Related]
79. [Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes]. Suzuki F Gan To Kagaku Ryoho; 1985 Jul; 12(7):1445-52. PubMed ID: 3874600 [TBL] [Abstract][Full Text] [Related]